PROCHLORPERAZINE

Course overview

PROCHLORPERAZINE IS A FIRST-GENERATION ANTIPSYCHOTIC. FDA INDICATIONS INCLUDE SCHIZOPHRENIA, SCHIZOAFFECTIVE, AND OTHER CONDITIONS PRESENTING WITH SYMPTOMS OF PSYCHOSIS, AS WELL AS NAUSEA AND VOMITING (POST-CHEMOTHERAPY, POST-RADIATION THERAPY, PRE- AND POST-OPERATIVE SETTING, AND OTHER CONDITIONS). NON-FDA INDICATIONS INCLUDE MIGRAINE HEADACHES. THIS ACTIVITY OUTLINES THE INDICATIONS, MECHANISM OF ACTION, METHODS OF ADMINISTRATION, SIGNIFICANT ADVERSE EFFECTS, CONTRAINDICATIONS, MONITORING, AND TOXICITY OF PROCHLORPERAZINE, SO PROVIDERS CAN DIRECT PATIENT THERAPY IN TREATING CONDITIONS FOR WHICH IT IS INDICATED, AS PART OF THE INTERPROFESSIONAL TEAM.